Sai Life Sciences Limited — Others, 17-06-2025: Appointment

Sai Life Sciences has announced that its members ratified the ESOP Scheme 2008 and Management ESOP Scheme 2018, including extending benefits to employees of its subsidiaries and group companies. The ESOP 2008 covers up to 60.99 lakh options with 3.68 lakh vested options, while the ESOP 2018 covers 79.45 lakh options with 12.96 lakh vested options. The company also appointed Dr. Dinesh V Patel as an Independent Director for a five-year term, bringing 38 years of pharmaceutical and biotech experience. Additionally, Mr. Sivaramakrishnan Chittor was appointed Whole-Time Director while continuing as CFO for five years, reinforcing leadership continuity.